Cargando…

The Food and Drug Administration and varenicline: should risk communication be improved?

Detalles Bibliográficos
Autores principales:	Davies, Neil M., Thomas, Kyla H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347897/ https://www.ncbi.nlm.nih.gov/pubmed/27558015 http://dx.doi.org/10.1111/add.13592

Ejemplares similares

Varenicline and Nicotine Replacement Use Associated With US Food and Drug Administration Drug Safety Communications
por: Desai, Ravi J., et al.
Publicado: (2019)

Could APO-varenicline and cytisine be solutions for the shortage of varenicline in Brazil?
por: Corrêa, Paulo César Rodrigues Pinto, et al.
Publicado: (2023)

Risk of neuropsychiatric adverse events associated with varenicline: systematic review and meta-analysis
por: Thomas, Kyla H, et al.
Publicado: (2015)

The effects of prescribing varenicline on two‐year health outcomes: an observational cohort study using electronic medical records
por: Davies, Neil M., et al.
Publicado: (2018)

Risk of neuropsychiatric and cardiovascular adverse events following treatment with varenicline and nicotine replacement therapy in the UK Clinical Practice Research Datalink: a case–cross‐over study
por: Thomas, Kyla H., et al.
Publicado: (2020)

Long-term effectiveness and safety of varenicline and nicotine replacement therapy in people with neurodevelopmental disorders: A prospective cohort study
por: Itani, Taha, et al.
Publicado: (2019)

What are the effects of varenicline compared with nicotine replacement therapy on long-term smoking cessation and clinically important outcomes? Protocol for a prospective cohort study
por: Davies, Neil M, et al.
Publicado: (2015)

Use of varenicline and nicotine replacement therapy in people with and without general practitioner-recorded dementia: retrospective cohort study of routine electronic medical records
por: Itani, Taha, et al.
Publicado: (2019)

The effectiveness of varenicline versus nicotine replacement therapy on long-term smoking cessation in primary care: a prospective cohort study of electronic medical records
por: Taylor, Gemma MJ, et al.
Publicado: (2017)

Addressing varenicline adherence through repackaging in a dose administration aid
por: Drovandi, Aaron D, et al.
Publicado: (2017)

Vaginal mesh grafts and the Food and Drug Administration
por: Ostergard, Donald R.
Publicado: (2010)

Smoking cessation therapy with varenicline
por: Mohanasundaram, Uma M, et al.
Publicado: (2008)

‘Food and medicine continuum’ – Why we should promote cross-cultural communication between the global East and West
por: Heinrich, Michael, et al.
Publicado: (2021)

Varenicline in the treatment of tobacco dependence
por: Fagerström, Karl, et al.
Publicado: (2008)

Cryptosporidiosis should be designated as a tropical disease by the US Food and Drug Administration
por: Choy, Robert K. M., et al.
Publicado: (2020)

Varenicline in smokers with diabetes: A pooled analysis of 15 randomized, placebo‐controlled studies of varenicline
por: Tonstad, Serena, et al.
Publicado: (2016)

Trends in food and drug administration inspection: A warning for the industry!
por: Shah, Kunal
Publicado: (2011)

Varenicline improves motor and cognitive symptoms in early Huntington’s disease
por: McGregor, Ailsa L, et al.
Publicado: (2016)

Assessment of the Risk of Suicide-Related Events Induced by Concomitant Use of Antidepressants in Cases of Smoking Cessation Treatment with Varenicline and Assessment of Latent Risk by the Use of Varenicline
por: Akimoto, Hayato, et al.
Publicado: (2016)

Prucalopride: A Recently Approved Drug by the Food and Drug Administration for Chronic Idiopathic Constipation
por: Mahajan, Rajiv
Publicado: (2019)

Drug-induced liver injury due to varenicline: a case report
por: Sprague, David, et al.
Publicado: (2012)

The clinical pharmacogeneticist: An emerging regulatory scientist at the US Food and Drug Administration
por: Zineh, Issam, et al.
Publicado: (2010)

Estatinas na Gestação – Novas Recomendações do Food and Drug Administration
por: Bittencourt, Marcio Sommer
Publicado: (2022)

Cardiovascular and neuropsychiatric risks of varenicline: a retrospective cohort study
por: Kotz, Daniel, et al.
Publicado: (2015)

Smoking cessation in Asians: focus on varenicline
por: Xiao, Dan, et al.
Publicado: (2015)

The psychiatric effects of varenicline on patients with depression
por: Yeung, EYH, et al.
Publicado: (2015)

Evaluation of the cardiovascular effects of varenicline in rats
por: Selçuk, Engin Burak, et al.
Publicado: (2015)

Varenicline and Risk of Self-Harm: A Nested Case-Control Study
por: Tadrous, Mina, et al.
Publicado: (2016)

Possible varenicline withdrawal-induced akathisia: A case report
por: Smith, Thomas R., et al.
Publicado: (2019)

Administrative data for observational research in multiple sclerosis: Opportunities and challenges
por: Marrie, Ruth Ann, et al.
Publicado: (2021)

Retreatment With Varenicline for Smoking Cessation in Smokers Who Have Previously Taken Varenicline: A Randomized, Placebo-Controlled Trial
por: Gonzales, D, et al.
Publicado: (2014)

Varenicline decreases alcohol consumption in heavy-drinking smokers
por: Mitchell, Jennifer M., et al.
Publicado: (2012)

Effect of Varenicline on Tardive Dyskinesia: A Pilot Study
por: Caroff, Stanley N., et al.
Publicado: (2021)

Blood test to help diagnose type 1 diabetes approved by Food and Drug Administration
por: Mahajan, Rajiv
Publicado: (2015)

Pilot safety evaluation of varenicline for the treatment of methamphetamine dependence
por: Zorick, Todd, et al.
Publicado: (2009)

Smoking cessation: an economic analysis and review of varenicline
por: Faulkner, Michele A
Publicado: (2009)

Identification, Isolation and Characterization of an Unknown Impurity of Varenicline
por: Satheesh, Balasubramanian, et al.
Publicado: (2012)

Varenicline: A review of the literature and place in therapy
por: Whitley, Heather P., et al.
Publicado: (2007)

Smoking cessation in Asians: focus on varenicline [Corrigendum]
Publicado: (2015)

Withdrawal-Emergent Dyskinesias following Varenicline Therapy
por: Toffey, Brittany A, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_llk5m2f0kh5ub6cekptqfjqfj1